In vivo experiments demonstrated that knocking down BST2 expression could significantly inhibit the proliferation of CRC while overexpression of BST2 enhanced tumor progression (Figure 6C-E, 6H-J). The gene discussed is BST2; the disease is colorectal carcinoma.